Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Cleary

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Human Molecular Genetics|August 7, 2013
Repeat-associated non-ATG (RAN) translation in neurological diseaseJohn D Cleary, Laura P W Ranum
Clinical Advances in Hematology & Oncology : H&O|June 20, 2009
Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin BRomuald Bellmann, John D Cleary, Jaroslav Sterba
The Journal of Antimicrobial Chemotherapy|March 5, 2009
Evidence that impurities contribute to the fluorescence of the polyene antibiotic amphotericin BJacques Bolard, John D Cleary, Robert E Kramer
The New England Journal of Medicine|February 7, 2009
Toll-like receptor 4 polymorphisms and aspergillosisStuart M Levitz, Shmuel Shoham, John D Cleary
The Annals of Pharmacotherapy|June 20, 2013
Herpes simplex virus encephalitis pharmacotherapy: alternative treatment optionsSavannah K Posey, John D Cleary, Pamela Evans
Journal of the Mississippi State Medical Association|March 1, 2012
T. asahii pulmonary infection as a complication of TNF-inhibitor and steroids: posaconazole pharmacotherapy and risk analysisSomjade Songcharoen, John D Cleary, John Jenkins, et al.
The Journal of Biological Chemistry|February 8, 2002
In vitro (CTG)*(CAG) expansions and deletions by human cell extractsGagan B Panigrahi, John D Cleary, Christopher E Pearson
Wiley Interdisciplinary Reviews. RNA|November 5, 2019
The potential of engineered eukaryotic RNA-binding proteins as molecular tools and therapeuticsCarl R Shotwell, John D Cleary, J Andrew Berglund
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|March 2, 2010
Medication-induced adverse effects: important concepts for the hand therapistDaniel M Riche, John D Cleary, S Travis King
Pharmacotherapy|May 14, 2003
Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulationsJohn D Cleary, P David Rogers, Stanley W Chapman
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Human Molecular Genetics|August 7, 2013
Repeat-associated non-ATG (RAN) translation in neurological diseaseJohn D Cleary, Laura P W Ranum
Clinical Advances in Hematology & Oncology : H&O|June 20, 2009
Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin BRomuald Bellmann, John D Cleary, Jaroslav Sterba
The Journal of Antimicrobial Chemotherapy|March 5, 2009
Evidence that impurities contribute to the fluorescence of the polyene antibiotic amphotericin BJacques Bolard, John D Cleary, Robert E Kramer
The New England Journal of Medicine|February 7, 2009
Toll-like receptor 4 polymorphisms and aspergillosisStuart M Levitz, Shmuel Shoham, John D Cleary
The Annals of Pharmacotherapy|June 20, 2013
Herpes simplex virus encephalitis pharmacotherapy: alternative treatment optionsSavannah K Posey, John D Cleary, Pamela Evans
Journal of the Mississippi State Medical Association|March 1, 2012
T. asahii pulmonary infection as a complication of TNF-inhibitor and steroids: posaconazole pharmacotherapy and risk analysisSomjade Songcharoen, John D Cleary, John Jenkins, et al.
The Journal of Biological Chemistry|February 8, 2002
In vitro (CTG)*(CAG) expansions and deletions by human cell extractsGagan B Panigrahi, John D Cleary, Christopher E Pearson
Wiley Interdisciplinary Reviews. RNA|November 5, 2019
The potential of engineered eukaryotic RNA-binding proteins as molecular tools and therapeuticsCarl R Shotwell, John D Cleary, J Andrew Berglund
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|March 2, 2010
Medication-induced adverse effects: important concepts for the hand therapistDaniel M Riche, John D Cleary, S Travis King
Pharmacotherapy|May 14, 2003
Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulationsJohn D Cleary, P David Rogers, Stanley W Chapman
Pageof 8